Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors
Circulation2023Vol. 147(13), pp. 1026–1038
Citations Over TimeTop 1% of 2023 papers
Truman J. Milling, Saskia Middeldorp, Lizhen Xu, Bruce Koch, Andrew M. Demchuk, John W. Eikelboom, Peter Verhamme, Alexander T. Cohen, Jan Beyer‐Westendorf, C. Michael Gibson, José López‐Sendón, Mark Crowther, Ashkan Shoamanesh, Michiel Coppens, Jeannot Schmidt, Pierre Albaladejo, Stuart J. Connolly, Ravinder Anand, Aveh Bastani, Carol L. Clark, Mauricio Concha, John A. Cornell, Keith Dombrowski, Gregory J. Fermann, James Fulmer, Joshua N. Goldstein, D.J. Kereiakes, Truman J. Milling, Daniel J. Pallin, Neha Patel, Majed A. Refaai, M. Rehman, Alvin H. Schmaier, E. Schwarz, William C. Shillinglaw, Michael Spohn, Tohru Takata, Arvind Venkat, James Welker, Ian J. Welsby, Joanna Y. Wilson, L. Van Keer, Franck Verschuren, Mark Blostein, John W. Eikelboom, Katharina Althaus, Jörg Berrouschot, Gary Braun, T. Doeppner, Rainer Dziewas, Sabine Genth‐Zotz, P. Greinacher, F. Hamann, Frank Hanses, W. Heide, Bernd Kallmuenzer, Pawel Kermer, Sven Poli, Georg Royl, Sebastian Schellong, Steffen Schnupp, Jürgen Schwarze, Claudia Spies, Götz Thomalla, Matthias von Mering, Karin Weißenborn, Frank A. Wollenweber, Christoph Gumbinger, Ulrich Jaschinski, M. Maschke, H-C. Mochmann, Waltraud Pfeilschifter, C. Pohlmann, Ralf Zahn, Pierre Bouzat, Jeannot Schmidt, Cristina Díez Vallejo, Bernard Floccard, Michiel Coppens, Sanne van Wissen, Eduardo Arellano‐Rodrigo, Ermengol Vallès, Raza Alikhan, Kerry J. Breen, Richard Hall, Mark Crowther, Pierre Albaladejo, Alexander T. Cohen, Andrew M. Demchuk, Jeannot Schmidt, D. George Wyse, D.A. Garcia, M.H. Prins, Juliet Nakamya, H.R. Büller, K. W. Mahaffey, John H. Alexander, John A. Cairns, R G Hart, Cameron D. Joyner, Gary E. Raskob, Sam Schulman, Roland Veltkamp, Brandi Meeks, Elena Zotova, Suhail Ahmad, Terezinha de Jesus Andreoli Pinto, Kenneth R. Baker, Andrea Dykstra, I. Holadyk-Gris, Antonio Malvaso, Andrew M. Demchuk
Abstract
gov; Unique identifier: NCT02329327.
Related Papers
- → The role of factor Xa inhibitors in venous thromboembolism treatment(2015)48 cited
- → Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban(2017)27 cited
- → Using New Oral Anticoagulants in Patients Undergoing Major Orthopedic Surgery(2015)5 cited
- → Novel Anticoagulants vs Warfarin for Stroke Prevention in Atrial Fibrillation(2014)1 cited
- → 43A Did blinding work in a trial of lipid-lowering and low-dose anticoagulant agents?(1995)